cover image: Short-acting spinal anesthetics for outpatient procedures

Premium

20.500.12592/s7wvx2

Short-acting spinal anesthetics for outpatient procedures

4 May 2011

In the past, lidocaine has been a popular choice as a spinal anesthetic due to rapid regression of sensory and motor block.1 However, its use has declined due to concerns about adverse events.2,3 One of these side effects, transient neurologic symptoms (TNS), manifests as light to severe pain originating in the buttocks and radiating to the lower extremities, which may be a sign of neurotoxicity.2 [...] The purpose of this review is to examine the clinical evidence and guidelines regarding optimal administration and safety of short-acting spinal anesthetics. [...] Of these, 12 described an adequate method of randomization,8-14,17-21 while the other two did not describe the randomization method.15,16 Both patients and outcome assessors were blinded in each trial, with the exception of one single- blind trial21 where outcome assessors were aware of the intervention. [...] Summary of findings Comparison of anesthetics One systematic review5 and four RCTs8,16,17,21 compared the use of bupivacaine with other spinal anaesthetics. [...] Lidocaine use was shown in one study13 to result in shorter time to sensory block recovery and discharge compared to ropivacaine but at the cost of higher rates of TNS and injection site pain.
health science and technology research systematic reviews drugs medical research medicine health care evidence-based medicine therapy evaluation studies anesthesia clinical medicine systematic review randomized controlled trials anesthetics evidence-based healthcare policy health treatment clinical government health care hospital and clinic bupivacaine local anesthetics anesthetic articaine anesthesia, spinal anaesthetics chloroprocaine spinal anesthesia
Pages
21
Published in
Canada

Related Topics

All